Congratulations, Yong Du, PhD, and George Zhang, PhD, on the Molecular Cancer Therapeutics Award for Outstanding Journal Article! Dr. Zhang is pictured with Assistant Editor Danielle Large, PhD. Learn more:
bit.ly/4daijw6
#FirstDisclosures #AACR24

Late tweet but worth it! Had a blast with PDAC legends at #AACR24 . Excited to present our data on neoadjuvant and adjuvant CAR T cell therapy use. AACR Mass General Cancer Center Mass General Surgery Cedars-Sinai Cedars-Sinai Gen Surg Residents

Don't miss WCM Englander Institute for Precision Medicine Clinical Director Dr. Cora Sternberg's (@cnsternberg) abstract 'Avelumab first-line maintenance for advanced #urothelialcarcinoma : long-term outcomes from #JAVELIN Bladder 100 in patients with low tumor burden,' ASCO! #AACR24 #PrecisionMedicine

Late #AACR24 post. Anna Dornisch presents P-CARE, an integrated risk model to be tested in the ProGRESS trial of precision #ProstateCancer screening #VA #MVP

Honored to be the recipient of the 2024 AACR Scholar-in-Training Award 🏆 I never thought I’d give a talk at the world’s biggest cancer research meeting, let alone be recognized for my work in the field. To those who walked this fulfilling journey with me, thank you! 🥂 #AACR24

Don't miss WCM Englander Institute for Precision Medicine Clinical Director Dr. Cora Sternberg's (@cnsternberg) abstract, 'Feasibility of implementing whole genome sequencing into routine #oncology care,' with First Author Dr. Pashtoon Kasi (@pashtoonkasi) ASCO! #WGS #AACR24 #PrecisionMedicine

Patient advocates at the recent AACR Annual Meeting in San Diego were connected with informative sessions, expert mentors, and a chance to share their knowledge through the AACR Scientist↔Survivor Program®. bit.ly/4b7HNsd #AACR24

⭐️Yes! The future IS now! “AI at the Interface: Accelerating Evidence Generation, Advancing Disparities Research, and Improving Trial Design” — Read a recap of this #AACR24 plenary session in AACR Annual Meeting News: bit.ly/4aROQ8q
Anant Madabhushi Thomas Clozel Mia Levy, MD, PhD

Did you catch us at #AACR24 ? If not, learn how iPair BCR/TCR sequencing allows you to validate tumor neoantigen peptides with patient-derived PBMCs, and accelerate your cancer vaccine development.

hubs.li/Q02sYGct0

#CancerResearch #ImmuneProfiling #NGS

Linvoseltamab: A Groundbreaking Advance in #MultipleMyeloma Treatment oncologytube.com/linvoseltamab-…
Dr. Sundar Jagannath @icahnmountsinai presented compelling data at #AACR24

Dozens of OHSU Knight Cancer Institute researchers shared discoveries and led sessions at the AACR Annual Meeting in San Diego, where more than 20,000 cancer researchers worldwide gathered April 5-10.

More from #AACR24 : spr.ly/6014bHcqn

⬆️
The structure of GFH375 (VS-7375) is believed to be included in patent WO2024061370A1. #AACR24
Keith Hornberger Anirban Maitra Benjamin Besse Aɴᴛᴏɴɪᴏ Pᴀssᴀʀᴏ Jonathan Ostrem Daniel Gerlach Darryl B McConnell John Taylor
🔻
synapse.patsnap.com/blog/genfleet-…

Two weeks later, we're still dreaming of #AACR24 and all the wonderful times talking science with colleagues and friends, old and new! Special shoutout to our fellows who received AACR Scholar-In-Training awards: Batel Blechter & Shahriar Zamani! dceg.cancer.gov/news-events/ne…

Thank you, to AACR, for orchestrating an exceptional conference! We're grateful for the opportunity to engage with fellow researchers, clinicians, and industry leaders, all working towards the same goal in the fight against cancer. #AACR24

Linvoseltamab demonstrates high efficacy in relapsed/refractory multiple myeloma. #AACR24 #MMSM

Our Faith E Davies shares why this may be groundbreaking for the triple-class-refractory treatment landscape in MedPage Today: bit.ly/4bfrw4P

We’ve had an exceptional response to the data we presented at #AACR24 and our clinical trial plans. If you’d like to learn more, DM me to set up a meeting.

At #AACR24 , we showcased our comprehensive ​immuno-oncology solution, RepSeq+. Learn how RepSeq+ quantifies any or all of the seven TCR and BCR chains for capturing clonal expansion during clinical trials:

hubs.li/Q02sYM-10

#ImmuneProfiling #Sequencing

Reunited with amazing #WomenInSTEM who are leaders in diversifying #CancerResearch … thank you #aacr24 for giving me extra determination to #MakeADifference

Blood Cancers Today met with calliecoombs, of UC Irvine UCI School of Medicine, at #AACR24 to hear about her recent research into the solid tumor microenvironment!

Watch here: buff.ly/3Q71ecI

🎉 Shoutout to Dennis Grencewicz, The Ohio State University College of Medicine student & AOA fellow, for his outstanding presentation at #AACR24 ! 🌟 His research on Candida albicans & its impact on colorectal tumors' response to radiotherapy is groundbreaking. Way to represent #OSUCOM ! 👏 Dennis Grencewicz